Cargando…
Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial
BACKGROUND: People with depression are usually managed in primary care and antidepressants are often the first-line treatment, but only one third of patients respond fully to a single antidepressant. This paper describes the protocol for a randomised controlled trial (MIR) to investigate the extent...
Autores principales: | Tallon, Debbie, Wiles, Nicola, Campbell, John, Chew-Graham, Carolyn, Dickens, Chris, Macleod, Una, Peters, Tim J., Lewis, Glyn, Anderson, Ian M., Gilbody, Simon, Hollingworth, William, Davies, Simon, Kessler, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526304/ https://www.ncbi.nlm.nih.gov/pubmed/26842107 http://dx.doi.org/10.1186/s13063-016-1199-2 |
Ejemplares similares
-
Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR)
por: Kessler, David S, et al.
Publicado: (2018) -
Does anxiety moderate the effectiveness of mirtazapine in patients with treatment-resistant depression? A secondary analysis of the MIR trial
por: Rifkin-Zybutz, Raphael, et al.
Publicado: (2020) -
Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trial
por: Gougoulaki, Marilia, et al.
Publicado: (2021) -
Mirtazapine Augmentation for Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: A Retropective Investigation
por: Atmaca, Murad, et al.
Publicado: (2011) -
Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis
por: Furukawa, Toshi A, et al.
Publicado: (2019)